Nanoparticles: a promising modality in the treatment of sarcomas
- PMID: 20505985
- DOI: 10.1007/s11095-010-0173-z
Nanoparticles: a promising modality in the treatment of sarcomas
Abstract
Improvements in surgical technique, chemotherapy, and radiotherapy have enhanced the prognosis of sarcoma patients, but have since reached a plateau in recent years. Novel approaches have been sought but with limited results. Nanomedicine offers solutions in diverse areas of sarcoma therapy including diagnosis and treatment. Several varieties of nanoparticles, including multifunctional nanoparticles, are available that localize the biodistribution of conventional chemotherapeutics to the tumor site. Also, nanoparticles loaded with chemotherapeutic drugs have the ability to overcome drug resistance which is a major obstacle impeding the progress of the treatment. Multifunctional nanoparticles, which have the potential to further augment the bioavailability of drugs, are being actively investigated. In this review, we will discuss the application of nanoparticles for improving the treatment of sarcoma patients.
Similar articles
-
New strategies in melanoma therapy: can nanoparticles overcome chemoresistance?Nanomedicine (Lond). 2017 Jul;12(14):1623-1626. doi: 10.2217/nnm-2017-0145. Epub 2017 Jun 21. Nanomedicine (Lond). 2017. PMID: 28635551 No abstract available.
-
Role of integrated cancer nanomedicine in overcoming drug resistance.Adv Drug Deliv Rev. 2013 Nov;65(13-14):1784-802. doi: 10.1016/j.addr.2013.07.012. Epub 2013 Jul 21. Adv Drug Deliv Rev. 2013. PMID: 23880506 Review.
-
Nanoparticle approaches to combating drug resistance.Future Med Chem. 2015 Aug;7(12):1503-10. doi: 10.4155/fmc.15.82. Epub 2015 Aug 27. Future Med Chem. 2015. PMID: 26334205 Review.
-
Recent progress in nanomedicine for enhanced cancer chemotherapy.Theranostics. 2021 Apr 19;11(13):6370-6392. doi: 10.7150/thno.57828. eCollection 2021. Theranostics. 2021. PMID: 33995663 Free PMC article. Review.
-
Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.Drug Resist Updat. 2017 Mar;31:15-30. doi: 10.1016/j.drup.2017.05.002. Epub 2017 May 21. Drug Resist Updat. 2017. PMID: 28867241 Review.
Cited by
-
Assessing the barriers to image-guided drug delivery.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Jan-Feb;6(1):1-14. doi: 10.1002/wnan.1247. Epub 2013 Oct 31. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014. PMID: 24339356 Free PMC article. Review.
-
Translation of nanotechnology-based implants for orthopedic applications: current barriers and future perspective.Front Bioeng Biotechnol. 2023 Aug 22;11:1206806. doi: 10.3389/fbioe.2023.1206806. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37675405 Free PMC article. Review.
-
p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines.Cancer Chemother Pharmacol. 2016 Feb;77(2):349-56. doi: 10.1007/s00280-015-2944-z. Epub 2015 Dec 23. Cancer Chemother Pharmacol. 2016. PMID: 26698867 Free PMC article.
-
Nanotechnology in orthopedics: a clinically oriented review.BMC Musculoskelet Disord. 2018 Mar 2;19(1):67. doi: 10.1186/s12891-018-1990-1. BMC Musculoskelet Disord. 2018. PMID: 29499666 Free PMC article. Review.
-
Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and market.J Chem Biol. 2012 Nov 30;6(1):7-23. doi: 10.1007/s12154-012-0086-x. eCollection 2012. J Chem Biol. 2012. PMID: 24294318 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical